ASH News TV 2018: Coverage of 60th ASH
congress program
Discover the establishment of a robust and reproducible in vitro screening
platform to support preclinical macrophage therapy and anti-CD47 agent
drug development. Learn how disrupting the CD47-SIRPa anti-phagocytic
axis is a novel immunotherapy approach against cancer.
Selected conferences
33ème Congrès International de la Society on Thrombosis and Haemostasis - ISTH 2025
- Date : 2025-06-21
-
307
0
Sommet Comprehensive Care de la Fédération Internationale de l'hémophilie – FMH 2025
- Date : 2025-04-23
-
73
0